4.5 Letter

Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors

期刊

CANCER COMMUNICATIONS
卷 40, 期 8, 页码 374-379

出版社

WILEY
DOI: 10.1002/cac2.12077

关键词

-

类别

资金

  1. National Medical Research Council Clinician-scientist award [NMRC/CSA/0027/2018]
  2. Health Commission of Hubei Province Scientific Research Project [WJ2019H002]
  3. Health Commission of Hubei Province Medical Leading Talent Project
  4. Fundamental Research Funds for the Central Universities [2042018kf1037, 2042019kf0329]
  5. Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]
  6. Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [znpy2017049, znpy2018070]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据